Beck A - Search Results

1

Therapeutic Fc-fusion proteins: Current analytical strategies.

Duivelshof BL, Murisier A, Camperi J, Fekete S, Beck A, Guillarme D, D'Atri V. Duivelshof BL, et al. Among authors: beck a. J Sep Sci. 2021 Jan;44(1):35-62. doi: 10.1002/jssc.202000765. Epub 2020 Sep 29. J Sep Sci. 2021. PMID: 32914936 Review.

2

Trends in glycosylation, glycoanalysis and glycoengineering of therapeutic antibodies and Fc-fusion proteins.

Beck A, Wagner-Rousset E, Bussat MC, Lokteff M, Klinguer-Hamour C, Haeuw JF, Goetsch L, Wurch T, Van Dorsselaer A, Corvaïa N. Beck A, et al. Curr Pharm Biotechnol. 2008 Dec;9(6):482-501. doi: 10.2174/138920108786786411. Curr Pharm Biotechnol. 2008. PMID: 19075687 Review.

3

[Therapeutic antibodies and related products: choosing the right structure for success].

Beck A, Wagner-Rousset E, Wurch T, Corvaia N. Beck A, et al. Med Sci (Paris). 2009 Dec;25(12):1024-32. doi: 10.1051/medsci/200925121024. Med Sci (Paris). 2009. PMID: 20035674 Free article. Review. French.

4

Strategies and challenges for the next generation of therapeutic antibodies.

Beck A, Wurch T, Bailly C, Corvaia N. Beck A, et al. Nat Rev Immunol. 2010 May;10(5):345-52. doi: 10.1038/nri2747. Nat Rev Immunol. 2010. PMID: 20414207 Review.

5

Cetuximab Fab and Fc N-glycan fast characterization using IdeS digestion and liquid chromatography coupled to electrospray ionization mass spectrometry.

Janin-Bussat MC, Tonini L, Huillet C, Colas O, Klinguer-Hamour C, Corvaïa N, Beck A. Janin-Bussat MC, et al. Among authors: beck a. Methods Mol Biol. 2013;988:93-113. doi: 10.1007/978-1-62703-327-5_7. Methods Mol Biol. 2013. PMID: 23475716

6

Theory and practice of size exclusion chromatography for the analysis of protein aggregates.

Fekete S, Beck A, Veuthey JL, Guillarme D. Fekete S, et al. Among authors: beck a. J Pharm Biomed Anal. 2014 Dec;101:161-73. doi: 10.1016/j.jpba.2014.04.011. Epub 2014 Apr 19. J Pharm Biomed Anal. 2014. PMID: 24816223 Review.

7

Method development for the separation of monoclonal antibody charge variants in cation exchange chromatography, Part I: salt gradient approach.

Fekete S, Beck A, Fekete J, Guillarme D. Fekete S, et al. Among authors: beck a. J Pharm Biomed Anal. 2015 Jan;102:33-44. doi: 10.1016/j.jpba.2014.08.035. Epub 2014 Sep 8. J Pharm Biomed Anal. 2015. PMID: 25240157

8

Adsorption and recovery issues of recombinant monoclonal antibodies in reversed-phase liquid chromatography.

Fekete S, Beck A, Wagner E, Vuignier K, Guillarme D. Fekete S, et al. Among authors: beck a. J Sep Sci. 2015 Jan;38(1):1-8. doi: 10.1002/jssc.201400996. Epub 2014 Dec 9. J Sep Sci. 2015. PMID: 25359277

9

Method development for the separation of monoclonal antibody charge variants in cation exchange chromatography, Part II: pH gradient approach.

Fekete S, Beck A, Fekete J, Guillarme D. Fekete S, et al. Among authors: beck a. J Pharm Biomed Anal. 2015 Jan;102:282-9. doi: 10.1016/j.jpba.2014.09.032. Epub 2014 Oct 5. J Pharm Biomed Anal. 2015. PMID: 25459925

10

Systematic evaluation of mobile phase additives for the LC-MS characterization of therapeutic proteins.

Bobály B, Beck A, Fekete J, Guillarme D, Fekete S. Bobály B, et al. Among authors: beck a. Talanta. 2015 May;136:60-7. doi: 10.1016/j.talanta.2014.12.006. Epub 2015 Jan 13. Talanta. 2015. PMID: 25702986

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,664 results

Search Page

Filters